Retroperitoneal Liposarcoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Retroperitoneal Liposarcoma

Who are the top Retroperitoneal Liposarcoma Local Doctors?
Elite in Retroperitoneal Liposarcoma
Surgical Oncology
Elite in Retroperitoneal Liposarcoma
Surgical Oncology

Brigham And Women's Hospital, Division Of Surgical Oncology

45 Francis Street, Asb2-3, 
Boston, MA 
Languages Spoken:
English

Dr. Raut is the Chief of the Division of Surgical Oncology and the inaugural Distinguished Chair for Cancer Care at Brigham and Women's Hospital. He received a BA and BS from Stanford University, MSc from University of Oxford, and MD from Harvard Medical School, where he is also a Professor of Surgery. He completed his residency in general surgery at Massachusetts General Hospital and fellowship in surgical oncology at MD Anderson Cancer Center. Dr. Raut specializes in the multidisciplinary care of patients with soft tissue sarcoma and serves as the Surgery Director for the Center for Sarcoma and Bone Oncology at Dana-Farber Brigham Cancer Center (DFBCC). His research focuses on multimodal strategies to reduce rates of local recurrence for patients with sarcoma. Dr. Raut is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Liposarcoma, Nephrectomy, and Pancreaticoduodenectomy. Dr. Raut is board certified in Surgery, General.

Elite in Retroperitoneal Liposarcoma
Surgical Oncology
Elite in Retroperitoneal Liposarcoma
Surgical Oncology

Winship Cancer Institute At Emory Midtown

36 Linden Avenue Northeast, 
Atlanta, GA 
Experience:
24+ years
Languages Spoken:
English, Spanish
Offers Telehealth

Kenneth Cardona is a Surgical Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 24 years. Dr. Cardona is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Retroperitoneal Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cardona is board certified in American Board Of Surgery, 2010.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Retroperitoneal Liposarcoma
Surgical Oncology
Elite in Retroperitoneal Liposarcoma
Surgical Oncology

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
Languages Spoken:
English

Christina Roland is a Surgical Oncologist practicing medicine in Cary, North Carolina. Dr. Roland is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

What are the latest Retroperitoneal Liposarcoma Clinical Trials?
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Summary: The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative R...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Characterization of the Genomic Risk Underlying Retroperitoneal Liposarcoma

Summary: The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur in locations within the retroperitoneum remote from the original primary tumor. This study hypothesizes that normal appearing retroperitoneal fat actually harbors underlying genetic changes which predi...

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center